Brinavess 500 mg, Konzentrat zur Herstellung einer Infusionslösung - Durchstechflasche(n) Swissmedic Key 61304003 Registration Holder Curatis AG Name Brinavess 500 mg, Konzentrat zur Herstellung einer Infusionslösung Date of registration 16.03.2011 Introduction of Sequence 16.03.2011 ATC-Classification Vernakalant (C01BG11) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.02. Show package size Durchstechflasche(n) Index Therapeuticus (Swissmedic) 02.02. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price 418.07 Deductible k.A. Consumer price 496.35 Feedback FB Daily cost GTIN 7680613040032 Medication Code Synthetika Pharmacode Disponibility
Composition vernakalanti hydrochloridum 500 mg corresp. vernakalantum 452.5 mg, acidum citricum monohydricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile ad solutionem pro 25 ml corresp. natrium 78.75 mg. Packungsbestandteile Galenic Form Concentrate for infusion Excipiens Active Agent Dose Vernakalanti Hydrochloridum 500mg / 25ml correspond Vernakalantum 452.5mg / 25ml
BAG: Active Agent Dose Vernakalanti Hydrochloridum 500 mg
Inactive agents Citric Acid Monohydrate Sodium Chloride Sodium Hydroxide
Source Data was imported : 04.02.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
